Ogen


Also found in: Dictionary.
Related to Ogen: estropipate

Ogen

 [o´jen]
trademark for preparations of estropipate, an estrone used in the treatment of estrogen deficiency.

estropipate

(ess-troe-pi-pate) ,

Ogen

(trade name),

Ortho-Est

(trade name)

Classification

Therapeutic: hormones
Pharmacologic: estrogens
Pregnancy Category: X

Indications

Oral: As part of HRT in the treatment of vasomotor symptoms of menopause.Treatment of various estrogen deficiency states, including:
  • Female hypogonadism,
  • Ovariectomy,
  • Primary ovarian failure.
Adjunctive therapy of postmenopausal osteoporosis.Concurrent use of progestin is recommended during cyclical therapy to decrease the risk of endometrial carcinoma in patients with an intact uterus.

Action

Estrogens promote the growth and development of female sex organs and the maintenance of secondary sex characteristics in women.
Metabolic effects include reduced blood cholesterol, protein synthesis, and sodium and water retention.

Therapeutic effects

Restoration of hormonal balance in various deficiency states.

Pharmacokinetics

Absorption: Well absorbed after oral administration.
Distribution: Widely distributed. Crosses the placenta and enters breast milk.
Metabolism and Excretion: Mostly metabolized by the liver and other tissues. Enterohepatic recirculation occurs, and more absorption may occur from the GI tract.
Half-life: Unknown.

Time/action profile (estrogenic effects)

ROUTEONSETPEAKDURATION
POunknown unknown24 hr

Contraindications/Precautions

Contraindicated in: Thromboembolic disease; Undiagnosed vaginal bleeding; Obstetric: Known to cause fetal harm; Lactation: ↓ quantity and quality of breast milk.
Use Cautiously in: Underlying cardiovascular disease; Severe hepatic or renal disease; May ↑ risk of endometrial carcinoma.

Adverse Reactions/Side Effects

(systemic use)

Central nervous system

  • headache (most frequent)
  • dizziness
  • lethargy
  • mental depression

Ear, Eye, Nose, Throat

  • intolerance to contact lenses (most frequent)
  • worsening of myopia or astigmatism

Cardiovascular

  • MI (life-threatening)
  • thromboembolism (life-threatening)
  • edema (most frequent)
  • hypertension (most frequent)

Gastrointestinal

  • nausea (most frequent)
  • weight changes (most frequent)
  • anorexia
  • ↑ appetite
  • jaundice
  • vomiting

Genitourinary

    women:
  • amenorrhea (most frequent)
  • breakthrough bleeding (most frequent)
  • dysmenorrhea (most frequent)
  • cervical erosion
  • loss of libido
  • vaginal candidiasis
  • men:
  • erectile dysfunction (most frequent)
  • testicular atrophy (most frequent)

Dermatologic

  • acne (most frequent)
  • oily skin (most frequent)
  • pigmentation
  • urticaria

Endocrinologic

  • gynecomastia (men) (most frequent)
  • hyperglycemia

Fluid and Electrolyte

  • hypercalcemia
  • sodium and water retention

Musculoskeletal

  • leg cramps

Miscellaneous

  • breast tenderness (most frequent)

Interactions

Drug-Drug interaction

May alter requirement for warfarin, oral hypoglycemic agents, or insulins.Barbiturates or rifampin may ↓ effectiveness.Smoking ↑ the risk of adverse cardiovascular reactions.

Route/Dosage

Vasomotor Symptoms of Menopause/Atrophic Vaginitis/Osteoporosis
Oral (Adults) 0.75–6 mg daily or in a cycle.
Female Hypogonadism/Ovarian Failure
Oral (Adults) 1.5–9 mg daily or in a cycle.

Availability (generic available)

Tablets: 0.75 mg, 1.5 mg, 3 mg, 6 mg

Nursing implications

Nursing assessment

  • Assess BP before and periodically throughout therapy.
    • Monitor intake and output ratios and weekly weight. Report significant discrepancies or steady weight gain.
  • Menopause: Assess frequency and severity of vasomotor symptoms.
  • Lab Test Considerations: May cause increased HDL, phospholipids, and triglycerides, and decreased serum LDL and total cholesterol concentrations.
    • May cause increased serum glucose, sodium, cortisol, prolactin, prothrombin, and factor VII, VIII, IX, and X levels. May decrease serum folate, pyridoxine, antithrombin III, and urine pregnanediol concentrations.
    • Monitor hepatic function before and periodically throughout therapy.
    • May cause false interpretations of thyroid function tests, false increases in norepinephrine platelet-induced aggregability, and false decreases in metyrapone tests.

Potential Nursing Diagnoses

Sexual dysfunction (Indications)

Implementation

  • Oral: Administer PO doses with or immediately after food to reduce nausea.
  • Vaginal: Manufacturer provides applicator with cream. Dose is marked on the applicator. Wash applicator with mild soap and warm water after each use.

Patient/Family Teaching

  • Instruct patient to take oral medication as directed. If a dose is missed, take as soon as remembered as long as it is not just before next dose. Do not double doses.
    • Explain medication schedule to women on 21-day cycle followed by 7 days of not taking medication. Encourage patient to take medication at the same time each day.
    • If nausea becomes a problem, advise patient that eating solid food often provides relief.
    • Advise patient to report signs and symptoms of fluid retention (swelling of ankles and feet, weight gain), thromboembolic disorders (pain, swelling, or tenderness in extremities; headache; chest pain; blurred vision), mental depression, hepatic dysfunction (yellowed skin or eyes, pruritus, dark urine, light-colored stools), or abnormal vaginal bleeding to health care professional.
    • Instruct patient to stop taking medication and notify health care professional if pregnancy is suspected.
    • Caution patient that cigarette smoking during estrogen therapy may increase risk of serious side effects, especially for women over age 35.
    • Caution patient to use sunscreen and protective clothing to prevent increased pigmentation.
    • Advise patient to notify health care professional of medication regimen before treatment or surgery.
    • Advise patient treated for osteoporosis that exercise has been found to arrest and reverse bone loss. The patient should discuss any exercise limitations with health care professional before beginning program.
    • Emphasize the importance of routine follow-up physical exams, including BP; breast, abdomen, and pelvic examinations; Papanicolaou smears every 6–12 mo; and mammogram every 12 mo or as directed. Health care professional will evaluate possibility of discontinuing medication every 3–6 mo. If on continuous (not cyclical) therapy or without concurrent progestins, endometrial biopsy may be recommended, if uterus is intact.
  • Vaginal: Instruct patient in the correct use of applicator. Patient should remain recumbent for at least 30 min after administration. May use sanitary napkin to protect clothing, but do not use tampon. If a dose is missed, do not use the missed dose, but return to regular dosing schedule.

Evaluation/Desired Outcomes

  • Resolution of menopausal vasomotor symptoms.
    • Decreased vaginal and vulvar itching, inflammation, or dryness associated with menopause.
  • Normalization of estrogen levels in patients with ovariectomy or hypogonadism.
  • Prevention of osteoporosis.

Ogen

(ō′jən)
A trademark for a drug containing estropipate.

Ogen

a trademark for an estrogen (estropipate).
References in periodicals archive ?
Mijn vaststelling is dat de nieuwe media zowel in het Nederlandse taalgebied als in de Afrikaanse literatuur van Zuid-Afrika nauwelijks worden ingezet om het ontregelende en dissonante geluid te laten horen dat Adorno met betrekking tot geengageerde kunst voor ogen stond.
Reg Ogen has been tasked with overseeing the creation of an Education and Training plan to get WFN members working in the construction phase of the project.
Speaking about this new venture, Ogen said: "Europe is very much a big part of our strategy to expand and bring growth to a market that has seen stagnation in traditional trading instruments".
It, rather, examines the historical figures "within the context of the socio-cultural relationships [with] other groups and individuals within their immediate and remote environments" (Arifalo and Ogen, 2006: 4).
Waar zijn de ogen waaruit de pijn tevoorschijn barstte?
Maar er bleef een ding over waarmee deze blanke zondaars zich niettemin verrieden: zij gaven aan hun verborgen kinderen een opvoeding die de kinderen en ook henzelf verdacht maakte in de ogen van anderen .
Act or James Franco debuted his star on Hollywood's iconic Walk of Fame in a ceremony followed by a crowd of curiosityseekers and where he was accompanied by movie director Sam R aimi and his comedt dian pal Seth R ogen.
Dan krijg ik wel eens tranen in mijn ogen niet van het begrepene maar doordat ik merk hoe kinderaehtig opgetogen ik weer ben met wat ik nooit bezat.
The global analysts were surprised to find that while Hadoop garners much of the spotlight as a Big Data platform, the vendor I Ogen, which develops MongoDB, came in second in mentions to Apache, which hosts the Hadoop project.
Eumichamo Fernando Eu oje dimanha Oiji foi muito bom pra mim oji di manha eu ogen eu jogei bola e depois levei u almoco.
Kim Irvine (14) won Division One from Pauline Pierce (14), Dilys Williams (13) Division Two from Ann Jones (12) and Linda Ogen (14) Division Three from Linda Vaughan (11)in a three clubs and a putter comp over eight holes.